收藏切换
The protective effect of Danning tablet against hepatic sinusoidal obstruction syndrome induced by Gynura Rhizoma
收藏切换
PDF
Long-hui LU1, 2, Fang ZHANG1, 2, Chang-sen ZHAN3, Ai-zhen XIONG1, *, Li YANG1, 2, *, Zheng-tao WANG1
Acta Pharmaceutica Sinica | 2019, 54(3) : 494 - 501
Less
收藏切换
Acta Pharmaceutica Sinica | 2019, 54(3): 494-501
Original Articles
The protective effect of Danning tablet against hepatic sinusoidal obstruction syndrome induced by Gynura Rhizoma
Full
Long-hui LU1, 2, Fang ZHANG1, 2, Chang-sen ZHAN3, Ai-zhen XIONG1, *, Li YANG1, 2, *, Zheng-tao WANG1
Affiliations
  • 1. The Ministry of Education Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai 201203, China
  • 2. Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • 3. Shanghai Hutchison Pharmaceuticals Co., Ltd., Shanghai 201401, China
Published: 2019-03-12 doi: 10.16438/j.0513-4870.2018-0793
Outline
收藏切换

Recently, hepatic sinusoidal obstruction syndrome (HSOS) caused by Gynura Rhizoma (Tusanqi) has gained global attention. The purpose of this research is to investigate the effects and mechanisms of Danning tablet, a traditional Chinese formula, on protecting against HSOS induced by Gynura Rhizoma. All experiments were approved by the Animal Research Committee of Shanghai University of Traditional Chinese Medicine. Animal welfare and the animal experimental protocols were strictly consistent with related ethics regulations of Shanghai University of Traditional Chinese Medicine. HSOS was induced by intragastrical administration of Gynura Rhizoma extract (1 g·kg-1·d-1) for 40 consencutive days. On the other hand, mice in the protection group were intragastrical administration of Danning tablet powder (3 g·kg-1·d-1) 4 hours before treatment of Gynura Rhizoma extract. The results showed that Danning tablet could significantly attenuate the liver injury in HSOS mice. Mice in the protection group showed decreased serum activity of spartate amino transferase, and levels of total bile acids and total bilirubin. In addition, the endothelial damage to the central venules, subendothelial hemorrhage, sinusoidal hemorrhage, and subendothelial fibrosis in HSOS mice were clearly attenuated in the protection group. Measurements of the key factors involved in liver fibrosis revealed that protection group showed significantly reduction in hepatic hydroxyproline concentration, mRNA expression of α-smooth muscle actin and fibrosis-related genes such as Collagen-1, Collagen-3, Mmp2 and Mmp9, as well as Smad3 phosphorylation (p-Smad) and serum transforming growth factor-β (TGF-β). Moreover, pro-inflammatory cytokines, including tumor necrosis factor-α and interleukin-1β, were also reversed in the protection group. All these results demonstrate the key roles of the TGF-β/p-Smad3 and inflammatory signaling pathways in the protection effect of Danning tablet on Gynura Rhizoma-induced HSOS, and pointing to the possibility of utilizing Danning tablet for protection against Gynura Rhizoma induced HSOS clinically.

Danning tablet  /  Gynura Rhizoma  /  pyrrolizidine alkaloids  /  hepatic sinusoidal obstruction syndrome  /  liver fibrosis
Long-hui LU, Fang ZHANG, Chang-sen ZHAN, Ai-zhen XIONG, Li YANG, Zheng-tao WANG. The protective effect of Danning tablet against hepatic sinusoidal obstruction syndrome induced by Gynura Rhizoma[J]. Acta Pharmaceutica Sinica, 2019 , 54 (3) : 494 -501 . DOI: 10.16438/j.0513-4870.2018-0793
Year 2019 volume 54 Issue 3
PDF
97
38
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2018-0793
  • Receive Date:2018-08-29
  • Online Date:2026-01-26
  • Published:2019-03-12
Article Data
Affiliations
History
  • Received:2018-08-29
  • Revised:2018-10-11
Funding
Affiliations
    1. The Ministry of Education Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai 201203, China
    2. Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    3. Shanghai Hutchison Pharmaceuticals Co., Ltd., Shanghai 201401, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2018-0793
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT